NASDAQ · Medical - Devices

iRadimed Corporation (IRMD) Stock

$88.27 -1.23% NASDAQ: IRMD Healthcare

Valuation

MetricValue
Price$88.27
Market Cap$1.13B
P/E Ratio47.37
P/B Ratio10.83
P/S Ratio12.77
EPS (TTM)$1.83
52-Week High$107.90
52-Week Low$68.68
Dividend Yield0.93%

Financials & Margins

MetricValue
ROE23.45%
ROA20.05%
ROCE26.04%
Gross Margin76.84%
Operating Margin32.40%
Net Margin26.70%
Debt/Equity0.00
Current Ratio8.10

Annual Financials (USD)

Metric20212022202320242025
Revenue$42.0M$53.0M$66.0M$73.0M$84.0M
Operating Profit$10.0M$16.0M$20.0M$22.0M$26.0M
Net Profit$9.0M$13.0M$17.0M$19.0M$22.0M
EPS$0.74$1.02$1.35$1.50$1.75
Op Margin23.5%29.3%30.6%30.0%31.2%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$83.0M$86.0M$92.0M$98.0M$109.0M
Total Liabilities$11.0M$12.0M$21.0M$12.0M$14.0M
Cash$62.0M$58.0M$50.0M$52.0M$51.0M
Borrowings$2.0M$2.0M$2.0M$0$0

Latest News

Iradimed Insider Sold Shares Worth $285,000, According to a Recent SEC Filing MT Newswires · Jun 4, 2026 Assessing IRADIMED (IRMD) Valuation After Strong Multi Year Returns And A Premium P/E Multiple Simply Wall St. · Jun 3, 2026 IRADIMED's CEO Is Selling Steadily — The Plan, Not the Stock, Is Driving It Motley Fool · Jun 2, 2026 Iradimed Insider Sold Shares Worth $691,044, According to a Recent SEC Filing MT Newswires · May 28, 2026 Iradimed Corp (IRMD): 3 Things That Stood Out From Q1 Report Insider Monkey · May 27, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$11.0M$10.0M$13.0M$26.0M$25.0M
Investing Cash Flow$0$-3.0M$-16.0M$-17.0M$-16.0M
Financing Cash Flow$0$0$0$-1.0M$-3.0M
Net Cash Flow$12.0M$-4.0M$-8.0M$2.0M$-1.0M
Free Cash Flow$11.0M$8.0M$5.0M$18.0M$17.0M

Valuation & Return Ratios

MetricValue
PEG Ratio4.06
EV / EBITDA33.53
FCF Yield2.26%
Quick Ratio8.13
Interest Coverage—
Return 1Y66.96%
Return 3Y116.15%
Return 5Y199.20%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $343.46 +0.43% 38.93 $5.01T 0.32%
MSFTMicrosoft Corporation $529.05 -1.93% 28.68 $3.93T 0.76%
GOOGLAlphabet Inc. $340.59 -2.47% 16.94 $4.14T 0.26%
AMZNAmazon.com, Inc. $250.00 -1.87% 19.82 $2.70T 0.00%
METAMeta Platforms, Inc. $709.33 -3.72% 27.93 $1.81T 0.28%

About iRadimed Corporation

iRadimed Corporation is led by CEO Roger E. Susi, employs 160 people, headquartered in US, publicly traded since 2014.

iRadimed Corporation (IRMD) stock trades at $88.27 with a market capitalization of $1.13B. The stock is valued at a price-to-earnings (P/E) ratio of 47.37, price-to-book of 10.83, price-to-sales of 12.77. Over the past 52 weeks the stock has ranged between $68.68 and $107.90, and currently trades 18.2% below its 52-week high. It pays a dividend yielding 0.93%.

On profitability, iRadimed Corporation generates a return on equity (ROE) of 23.45%, above the typical market range of roughly 12-15%, return on capital employed of 26.04%, an operating margin of 32.40%, a net profit margin of 26.70%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1257.03 +0.43% JNJ Johnson & Johnson $255.56 +0.90% ABBV AbbVie Inc. $285.42 +0.71% UNH UnitedHealth Group Incorporated Common Stock (DE) $401.43 -1.29% MRK Merck & Company, Inc. Common Stock (new) $145.97 +0.53% NVS Novartis AG $150.62 +0.16% AZN AstraZeneca PLC $165.41 -0.76% TMO Thermo Fisher Scientific Inc $690.00 -0.93% AMGN Amgen Inc. $432.49 -0.35% GILD Gilead Sciences, Inc. $156.19 -0.75% ABT Abbott Laboratories $104.88 +0.19% NVO Novo Nordisk A/S $38.83 -0.99%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.